Open AccessSAT-LB025 Analysis of Benefit/Risk in the Subgroup of Patients with BMI of >=27 Kg/m2 in the Dapagliflozin DEPICT-1 and -2 Trials in Type 1 Diabetes
Author(s) -
Chantal Mathieu,
Paresh Dandona,
Moshe Phillip,
John Xu,
Fredrik Thorén,
Markus F. Scheerer,
AM Langkilde
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-lb025
Subject(s) - dapagliflozin , medicine , incidence (geometry) , subgroup analysis , population , clinical endpoint , type 2 diabetes , hazard ratio , diabetes mellitus , type 1 diabetes , randomized controlled trial , endocrinology , confidence interval , mathematics , geometry , environmental health